Filter results
70616:00
SPARK Europe invites you to our next webinar on new Clinical Trials Regulation which was implemented on 31th of January 2022 and we are in the three-year transition period now. All initial clinical trials applications must be submitted through Clinical Trial Information System (CTIS). We will ...
100516:00
Hidden tips for success in healthcare
10 May 2023 | 16-17 CET | panel discussion
SPARK Europe invites you to our next Innovator Café where the panellists, who have been bench-scientists not too long ago, will reveal what it is like when a scientist turns into an entrepreneur and ...
120416:00
How to select the right first indication for your platform technology?
12 April 2023 | 16-17 CET | Peter Nestorov, PhD
SPARK Europe invites you to our next webinar organized by Spark Zürich with Peter Nestorov, PhD, a co-founder and CEO of Scailyte – a spin-off with an ...
240316:00
Nencki Institute as a representative of SPARK Poland within the SPARK Europe would like to cordially invite you to participate in the next webinar of European SPARKs joint series on March 24th, 16-17 CET.
During the webinar titled “Why can’t I be Elon? The challenge of selling complex ...
100316:00
Nencki Institute as a representative of SPARK Poland within the SPARK Europe would like to cordially invite you to participate in the next webinar of European SPARKs joint series on March 10th, 16-17 CET.
During the “Innovate without losing your shirt” webinar we will gain insight into how ...
100216:00
Nencki Institute as a representative of SPARK Poland within the SPARK Europe would like to cordially invite you to participate in the next webinar of European SPARKs joint series on February 10th, 16-17 CET.
The webinar titled “Are you willing to pay for it? - How to find a product-market ...
270116:00
I would like to remind you of the second webinar of European SPARKs joint series on January 27, 16-17 CET. The webinar titled "Design Thinking for Health Innovation" will be held by Jeremias Schmitt, innovation professional and Head of Transformation and Strategy at Fuenfwerken Design. He will ...
Instytut Nenckiego wraz z Pikralida Sp. z o. o. realizują projekt dofinansowany z Funduszy Europejskich pt. "Zastosowanie inhibitora metaloproteazy macierzowej do opracowania innowacyjnej metody terapeutycznej zapobiegania rozwojowi padaczki pourazowej i poudarowej".
Celem Projektu jest ...